

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | angiotensin maturation (GO:0002003) | 8.15467568 |
| 2 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 7.41902924 |
| 3 | drug transmembrane transport (GO:0006855) | 7.27363257 |
| 4 | intestinal absorption (GO:0050892) | 6.75216284 |
| 5 | very-low-density lipoprotein particle assembly (GO:0034379) | 6.74006220 |
| 6 | urate metabolic process (GO:0046415) | 6.60788758 |
| 7 | NADH metabolic process (GO:0006734) | 6.34381283 |
| 8 | axon ensheathment in central nervous system (GO:0032291) | 6.32910477 |
| 9 | central nervous system myelination (GO:0022010) | 6.32910477 |
| 10 | regulation of bile acid biosynthetic process (GO:0070857) | 6.25419720 |
| 11 | plasma lipoprotein particle assembly (GO:0034377) | 6.22796833 |
| 12 | drug transport (GO:0015893) | 5.92903014 |
| 13 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.92398525 |
| 14 | regulation of guanylate cyclase activity (GO:0031282) | 5.82658104 |
| 15 | phosphate ion transport (GO:0006817) | 5.79988632 |
| 16 | exogenous drug catabolic process (GO:0042738) | 5.75848166 |
| 17 | protein-lipid complex assembly (GO:0065005) | 5.54235071 |
| 18 | L-phenylalanine catabolic process (GO:0006559) | 5.52427197 |
| 19 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.52427197 |
| 20 | lipoprotein transport (GO:0042953) | 5.49990433 |
| 21 | cysteine metabolic process (GO:0006534) | 5.47725251 |
| 22 | organic cation transport (GO:0015695) | 5.43642912 |
| 23 | phosphate ion transmembrane transport (GO:0035435) | 5.42021205 |
| 24 | fructose metabolic process (GO:0006000) | 5.38434000 |
| 25 | glyoxylate metabolic process (GO:0046487) | 5.32068140 |
| 26 | phosphate ion homeostasis (GO:0055062) | 5.29913188 |
| 27 | trivalent inorganic anion homeostasis (GO:0072506) | 5.29913188 |
| 28 | epoxygenase P450 pathway (GO:0019373) | 5.24272136 |
| 29 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.23540711 |
| 30 | fat-soluble vitamin biosynthetic process (GO:0042362) | 5.21850353 |
| 31 | drug catabolic process (GO:0042737) | 5.21096701 |
| 32 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.17069270 |
| 33 | L-phenylalanine metabolic process (GO:0006558) | 5.17069270 |
| 34 | diacylglycerol metabolic process (GO:0046339) | 5.10085157 |
| 35 | regulation of cholesterol homeostasis (GO:2000188) | 5.01320011 |
| 36 | regulation of cholesterol esterification (GO:0010872) | 4.93423488 |
| 37 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 4.80812281 |
| 38 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 4.80812281 |
| 39 | endocrine process (GO:0050886) | 4.80812281 |
| 40 | low-density lipoprotein particle remodeling (GO:0034374) | 4.78368923 |
| 41 | high-density lipoprotein particle remodeling (GO:0034375) | 4.77514182 |
| 42 | response to lead ion (GO:0010288) | 4.74106892 |
| 43 | lysine metabolic process (GO:0006553) | 4.71106578 |
| 44 | lysine catabolic process (GO:0006554) | 4.71106578 |
| 45 | aspartate family amino acid catabolic process (GO:0009068) | 4.65410326 |
| 46 | plasma lipoprotein particle organization (GO:0071827) | 4.63147865 |
| 47 | maintenance of gastrointestinal epithelium (GO:0030277) | 4.62027336 |
| 48 | proline biosynthetic process (GO:0006561) | 4.60514510 |
| 49 | plasma lipoprotein particle remodeling (GO:0034369) | 4.54952518 |
| 50 | protein-lipid complex remodeling (GO:0034368) | 4.54952518 |
| 51 | macromolecular complex remodeling (GO:0034367) | 4.54952518 |
| 52 | vitamin transmembrane transport (GO:0035461) | 4.51919370 |
| 53 | response to mercury ion (GO:0046689) | 4.51099567 |
| 54 | nonribosomal peptide biosynthetic process (GO:0019184) | 4.47572862 |
| 55 | response to methylmercury (GO:0051597) | 4.45998382 |
| 56 | myelin maintenance (GO:0043217) | 4.45890331 |
| 57 | phospholipid efflux (GO:0033700) | 4.41129072 |
| 58 | protein-lipid complex subunit organization (GO:0071825) | 4.35426235 |
| 59 | positive regulation of guanylate cyclase activity (GO:0031284) | 4.31921169 |
| 60 | regulation of systemic arterial blood pressure (GO:0003073) | 4.30829352 |
| 61 | reverse cholesterol transport (GO:0043691) | 4.30004770 |
| 62 | quaternary ammonium group transport (GO:0015697) | 4.26033969 |
| 63 | urea cycle (GO:0000050) | 4.24281483 |
| 64 | glutathione biosynthetic process (GO:0006750) | 4.21980964 |
| 65 | amyloid precursor protein metabolic process (GO:0042982) | 4.17101282 |
| 66 | regulation of triglyceride catabolic process (GO:0010896) | 4.16104677 |
| 67 | glycosphingolipid catabolic process (GO:0046479) | 4.07895931 |
| 68 | lipoprotein metabolic process (GO:0042157) | 4.06412014 |
| 69 | urea metabolic process (GO:0019627) | 3.98034294 |
| 70 | aromatic amino acid family catabolic process (GO:0009074) | 3.97892229 |
| 71 | glycolipid catabolic process (GO:0019377) | 3.97044762 |
| 72 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.96869134 |
| 73 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.96869134 |
| 74 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.88503025 |
| 75 | carnitine metabolic process (GO:0009437) | 3.88102828 |
| 76 | short-chain fatty acid metabolic process (GO:0046459) | 3.86440812 |
| 77 | sodium-independent organic anion transport (GO:0043252) | 3.83152366 |
| 78 | bile acid and bile salt transport (GO:0015721) | 3.77183944 |
| 79 | renal system process involved in regulation of blood volume (GO:0001977) | 3.72680301 |
| 80 | serine family amino acid metabolic process (GO:0009069) | 3.72318009 |
| 81 | response to phenylpropanoid (GO:0080184) | 3.70142708 |
| 82 | amino-acid betaine metabolic process (GO:0006577) | 3.69477963 |
| 83 | homocysteine metabolic process (GO:0050667) | 3.68873777 |
| 84 | cholesterol efflux (GO:0033344) | 3.68482825 |
| 85 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.68153175 |
| 86 | cholesterol homeostasis (GO:0042632) | 3.67120981 |
| 87 | nitrogen cycle metabolic process (GO:0071941) | 3.65507060 |
| 88 | regulation of cholesterol metabolic process (GO:0090181) | 3.64999259 |
| 89 | serine family amino acid biosynthetic process (GO:0009070) | 3.64770793 |
| 90 | hormone catabolic process (GO:0042447) | 3.62488642 |
| 91 | drug metabolic process (GO:0017144) | 3.62278896 |
| 92 | glutathione derivative metabolic process (GO:1901685) | 3.61907357 |
| 93 | glutathione derivative biosynthetic process (GO:1901687) | 3.61907357 |
| 94 | sterol homeostasis (GO:0055092) | 3.61164664 |
| 95 | amyloid precursor protein catabolic process (GO:0042987) | 3.57609491 |
| 96 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.53302622 |
| 97 | epithelial structure maintenance (GO:0010669) | 3.52538739 |
| 98 | regulation of cGMP biosynthetic process (GO:0030826) | 3.50797179 |
| 99 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.47997621 |
| 100 | GDP-mannose metabolic process (GO:0019673) | 3.47409664 |
| 101 | digestive system process (GO:0022600) | 3.45219590 |
| 102 | beta-amyloid metabolic process (GO:0050435) | 3.43270370 |
| 103 | female mating behavior (GO:0060180) | 3.36702610 |
| 104 | regulation of extracellular matrix disassembly (GO:0010715) | 3.36056586 |
| 105 | proline metabolic process (GO:0006560) | 3.35729572 |
| 106 | creatine metabolic process (GO:0006600) | 3.34788154 |
| 107 | regulation of female receptivity (GO:0045924) | 3.33279005 |
| 108 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.32748804 |
| 109 | myelination (GO:0042552) | 3.32674127 |
| 110 | ensheathment of neurons (GO:0007272) | 3.31816164 |
| 111 | axon ensheathment (GO:0008366) | 3.31816164 |
| 112 | aldehyde catabolic process (GO:0046185) | 3.31525926 |
| 113 | toxin transport (GO:1901998) | 3.31438876 |
| 114 | linoleic acid metabolic process (GO:0043651) | 3.30747994 |
| 115 | cellular modified amino acid catabolic process (GO:0042219) | 3.29303972 |
| 116 | oligosaccharide catabolic process (GO:0009313) | 3.28161805 |
| 117 | drinking behavior (GO:0042756) | 3.27727701 |
| 118 | arginine metabolic process (GO:0006525) | 3.27703537 |
| 119 | glutathione metabolic process (GO:0006749) | 3.25474342 |
| 120 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.24136237 |
| 121 | positive regulation of lipid catabolic process (GO:0050996) | 3.23033599 |
| 122 | antibacterial humoral response (GO:0019731) | 3.22869004 |
| 123 | cellular anion homeostasis (GO:0030002) | 3.21195898 |
| 124 | ceramide catabolic process (GO:0046514) | 3.20683378 |
| 125 | intestinal cholesterol absorption (GO:0030299) | 3.17982597 |
| 126 | regulation of cellular extravasation (GO:0002691) | 3.17567537 |
| 127 | glucuronate metabolic process (GO:0019585) | 3.16439993 |
| 128 | uronic acid metabolic process (GO:0006063) | 3.16439993 |
| 129 | fatty acid beta-oxidation (GO:0006635) | 3.15221253 |
| 130 | peptide biosynthetic process (GO:0043043) | 3.13241130 |
| 131 | alpha-linolenic acid metabolic process (GO:0036109) | 3.12650128 |
| 132 | antimicrobial humoral response (GO:0019730) | 3.12481202 |
| 133 | dopamine biosynthetic process (GO:0042416) | 3.11996535 |
| 134 | bile acid metabolic process (GO:0008206) | 3.11279929 |
| 135 | peptide hormone processing (GO:0016486) | 3.11182703 |
| 136 | cellular glucuronidation (GO:0052695) | 3.10358797 |
| 137 | serine family amino acid catabolic process (GO:0009071) | 3.10255854 |
| 138 | L-ascorbic acid metabolic process (GO:0019852) | 3.09779157 |
| 139 | fatty acid oxidation (GO:0019395) | 3.05573006 |
| 140 | excretion (GO:0007588) | 3.04407393 |
| 141 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.03863681 |
| 142 | ethanol metabolic process (GO:0006067) | 3.02385100 |
| 143 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 3.00909896 |
| 144 | vitamin transport (GO:0051180) | 3.00046916 |
| 145 | very long-chain fatty acid metabolic process (GO:0000038) | 2.99989203 |
| 146 | lipid oxidation (GO:0034440) | 2.99824334 |
| 147 | glutamate metabolic process (GO:0006536) | 2.99685768 |
| 148 | tricarboxylic acid metabolic process (GO:0072350) | 2.99442311 |
| 149 | carnitine transport (GO:0015879) | 2.98420006 |
| 150 | amino-acid betaine transport (GO:0015838) | 2.98420006 |
| 151 | virion attachment to host cell (GO:0019062) | 2.97523766 |
| 152 | adhesion of symbiont to host cell (GO:0044650) | 2.97523766 |
| 153 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.96721156 |
| 154 | regulation of lipoprotein metabolic process (GO:0050746) | 2.93643600 |
| 155 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.93022991 |
| 156 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.92987669 |
| 157 | primary alcohol catabolic process (GO:0034310) | 2.92521769 |
| 158 | O-glycan processing (GO:0016266) | 2.91690616 |
| 159 | fatty acid elongation (GO:0030497) | 2.91623196 |
| 160 | digestion (GO:0007586) | 2.90978932 |
| 161 | positive regulation of pseudopodium assembly (GO:0031274) | 2.89649962 |
| 162 | branched-chain amino acid metabolic process (GO:0009081) | 2.86706280 |
| 163 | fatty acid catabolic process (GO:0009062) | 2.86693471 |
| 164 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.86393695 |
| 165 | metanephric tubule development (GO:0072170) | 2.83031364 |
| 166 | metanephric nephron tubule development (GO:0072234) | 2.83031364 |
| 167 | peptide catabolic process (GO:0043171) | 2.82908234 |
| 168 | cellular amino acid catabolic process (GO:0009063) | 2.81102192 |
| 169 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.81072953 |
| 170 | flavonoid metabolic process (GO:0009812) | 2.80672624 |
| 171 | vitamin D metabolic process (GO:0042359) | 2.80322067 |
| 172 | aromatic amino acid family metabolic process (GO:0009072) | 2.80116261 |
| 173 | acetyl-CoA metabolic process (GO:0006084) | 2.79916304 |
| 174 | modified amino acid transport (GO:0072337) | 2.78906183 |
| 175 | metanephric nephron epithelium development (GO:0072243) | 2.78383718 |
| 176 | desmosome organization (GO:0002934) | 2.77692211 |
| 177 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.76281336 |
| 178 | neurotransmitter biosynthetic process (GO:0042136) | 2.75771114 |
| 179 | sphingosine metabolic process (GO:0006670) | 2.74979420 |
| 180 | alpha-amino acid catabolic process (GO:1901606) | 2.74340210 |
| 181 | negative regulation of response to reactive oxygen species (GO:1901032) | 2.73880529 |
| 182 | tryptophan metabolic process (GO:0006568) | 2.71426099 |
| 183 | indole-containing compound catabolic process (GO:0042436) | 2.70886446 |
| 184 | indolalkylamine catabolic process (GO:0046218) | 2.70886446 |
| 185 | tryptophan catabolic process (GO:0006569) | 2.70886446 |
| 186 | ATP synthesis coupled proton transport (GO:0015986) | 2.65025909 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.29279394 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.18241402 |
| 3 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.57384797 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.22966749 |
| 5 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.08879952 |
| 6 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.74901581 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.74845018 |
| 8 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.70848566 |
| 9 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.69597366 |
| 10 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.57951652 |
| 11 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.57278734 |
| 12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.46714657 |
| 13 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.35615595 |
| 14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.32397634 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.08423276 |
| 16 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.02481206 |
| 17 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.92410283 |
| 18 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.81941084 |
| 19 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.79382807 |
| 20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.74923931 |
| 21 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.73980742 |
| 22 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.72343040 |
| 23 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.67660910 |
| 24 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.56997040 |
| 25 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.56050931 |
| 26 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.53617877 |
| 27 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.49589336 |
| 28 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.48943283 |
| 29 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.48862661 |
| 30 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.48173941 |
| 31 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.45638407 |
| 32 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.45372138 |
| 33 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.44620564 |
| 34 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.43480807 |
| 35 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.41591391 |
| 36 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.41405912 |
| 37 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.41227488 |
| 38 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.40525456 |
| 39 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.38290252 |
| 40 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.37613501 |
| 41 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.36958757 |
| 42 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.34452873 |
| 43 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.34412473 |
| 44 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.32879065 |
| 45 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.32290971 |
| 46 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.31296570 |
| 47 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.31177379 |
| 48 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.30850416 |
| 49 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.30282956 |
| 50 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.29695850 |
| 51 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.29647113 |
| 52 | RXR_22108803_ChIP-Seq_LS180_Human | 1.28163699 |
| 53 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.26317275 |
| 54 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.26269546 |
| 55 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.25958239 |
| 56 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.25851673 |
| 57 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.24615224 |
| 58 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.24319382 |
| 59 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.23461945 |
| 60 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.23110980 |
| 61 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.22649118 |
| 62 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21383712 |
| 63 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.20649808 |
| 64 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.20242890 |
| 65 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.19648867 |
| 66 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.19580685 |
| 67 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.19293571 |
| 68 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.14801604 |
| 69 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.14237166 |
| 70 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.13870466 |
| 71 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.13046857 |
| 72 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.12758528 |
| 73 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.11814058 |
| 74 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.10604297 |
| 75 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.09884995 |
| 76 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.08975678 |
| 77 | P68_20966046_ChIP-Seq_HELA_Human | 1.08735868 |
| 78 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.08384770 |
| 79 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.08262599 |
| 80 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.08143116 |
| 81 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.08143116 |
| 82 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.07871087 |
| 83 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.07602897 |
| 84 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.07301800 |
| 85 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.06721874 |
| 86 | MYC_22102868_ChIP-Seq_BL_Human | 1.06281585 |
| 87 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.06050724 |
| 88 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.05586280 |
| 89 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.04924182 |
| 90 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.04709968 |
| 91 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.04397034 |
| 92 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.03863714 |
| 93 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.03769594 |
| 94 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.03453384 |
| 95 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.03253606 |
| 96 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.03148001 |
| 97 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.02864450 |
| 98 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.02732109 |
| 99 | GATA1_22025678_ChIP-Seq_K562_Human | 1.01299780 |
| 100 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.01064218 |
| 101 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.99232117 |
| 102 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.98864384 |
| 103 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.98554295 |
| 104 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.98083319 |
| 105 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.97896315 |
| 106 | GATA1_19941826_ChIP-Seq_K562_Human | 0.97008058 |
| 107 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97005633 |
| 108 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.96838148 |
| 109 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.96598128 |
| 110 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.95200573 |
| 111 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.95126897 |
| 112 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.93981416 |
| 113 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.93837007 |
| 114 | GATA2_19941826_ChIP-Seq_K562_Human | 0.93206402 |
| 115 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.92452214 |
| 116 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.92352884 |
| 117 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.92041803 |
| 118 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.92041803 |
| 119 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.91286003 |
| 120 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.91239583 |
| 121 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.90836026 |
| 122 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.90650890 |
| 123 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.89315009 |
| 124 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.88997389 |
| 125 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.88798938 |
| 126 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.88263152 |
| 127 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.88186333 |
| 128 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.88114391 |
| 129 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.88114391 |
| 130 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.87004838 |
| 131 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.86896144 |
| 132 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.86135535 |
| 133 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.85679621 |
| 134 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.85449243 |
| 135 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.85193863 |
| 136 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.84950114 |
| 137 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.84921473 |
| 138 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.84431360 |
| 139 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.83907996 |
| 140 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.83123836 |
| 141 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.82272363 |
| 142 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.81994618 |
| 143 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.81624409 |
| 144 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.80597625 |
| 145 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.77887948 |
| 146 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.77131004 |
| 147 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.77084105 |
| 148 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.75829647 |
| 149 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.75786984 |
| 150 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.74098296 |
| 151 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.73436860 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.66389084 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.60831552 |
| 3 | MP0004043_abnormal_pH_regulation | 4.04617593 |
| 4 | MP0003183_abnormal_peptide_metabolism | 3.78438663 |
| 5 | MP0004019_abnormal_vitamin_homeostasis | 3.63112219 |
| 6 | MP0003950_abnormal_plasma_membrane | 3.51167023 |
| 7 | MP0000920_abnormal_myelination | 3.48091409 |
| 8 | MP0004264_abnormal_extraembryonic_tissu | 3.47340427 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 3.42994107 |
| 10 | MP0005332_abnormal_amino_acid | 3.28333615 |
| 11 | MP0002138_abnormal_hepatobiliary_system | 3.03777183 |
| 12 | MP0005058_abnormal_lysosome_morphology | 2.87209619 |
| 13 | MP0008875_abnormal_xenobiotic_pharmacok | 2.81022721 |
| 14 | MP0005085_abnormal_gallbladder_physiolo | 2.74131720 |
| 15 | MP0009643_abnormal_urine_homeostasis | 2.47480610 |
| 16 | MP0010155_abnormal_intestine_physiology | 2.33960328 |
| 17 | MP0001765_abnormal_ion_homeostasis | 2.33190674 |
| 18 | MP0002796_impaired_skin_barrier | 2.33181044 |
| 19 | MP0003656_abnormal_erythrocyte_physiolo | 2.26922859 |
| 20 | MP0009379_abnormal_foot_pigmentation | 2.20702114 |
| 21 | MP0000678_abnormal_parathyroid_gland | 2.19568918 |
| 22 | MP0003195_calcinosis | 2.19325937 |
| 23 | MP0003690_abnormal_glial_cell | 2.17054898 |
| 24 | MP0005636_abnormal_mineral_homeostasis | 2.03329215 |
| 25 | MP0003252_abnormal_bile_duct | 1.96938827 |
| 26 | MP0001958_emphysema | 1.95465680 |
| 27 | MP0003868_abnormal_feces_composition | 1.94912481 |
| 28 | MP0003329_amyloid_beta_deposits | 1.85677939 |
| 29 | MP0002136_abnormal_kidney_physiology | 1.81847793 |
| 30 | MP0005451_abnormal_body_composition | 1.80715640 |
| 31 | MP0003866_abnormal_defecation | 1.78596538 |
| 32 | MP0006082_CNS_inflammation | 1.72930062 |
| 33 | MP0009840_abnormal_foam_cell | 1.65715913 |
| 34 | MP0003191_abnormal_cellular_cholesterol | 1.63439679 |
| 35 | MP0004858_abnormal_nervous_system | 1.63379793 |
| 36 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.62287021 |
| 37 | MP0000490_abnormal_crypts_of | 1.60753799 |
| 38 | MP0000477_abnormal_intestine_morphology | 1.53469135 |
| 39 | MP0010352_gastrointestinal_tract_polyps | 1.53036872 |
| 40 | MP0005501_abnormal_skin_physiology | 1.52904927 |
| 41 | MP0002166_altered_tumor_susceptibility | 1.52241735 |
| 42 | MP0000604_amyloidosis | 1.51835782 |
| 43 | MP0010234_abnormal_vibrissa_follicle | 1.50828828 |
| 44 | MP0003186_abnormal_redox_activity | 1.49474356 |
| 45 | MP0001756_abnormal_urination | 1.43925036 |
| 46 | MP0005670_abnormal_white_adipose | 1.41830834 |
| 47 | MP0001764_abnormal_homeostasis | 1.38768159 |
| 48 | MP0000566_synostosis | 1.36019323 |
| 49 | MP0004885_abnormal_endolymph | 1.35954161 |
| 50 | MP0003879_abnormal_hair_cell | 1.30791517 |
| 51 | MP0003718_maternal_effect | 1.30781179 |
| 52 | MP0004185_abnormal_adipocyte_glucose | 1.30690656 |
| 53 | MP0003880_abnormal_central_pattern | 1.25832257 |
| 54 | MP0001873_stomach_inflammation | 1.25485579 |
| 55 | MP0005377_hearing/vestibular/ear_phenot | 1.25331705 |
| 56 | MP0003878_abnormal_ear_physiology | 1.25331705 |
| 57 | MP0000538_abnormal_urinary_bladder | 1.23921231 |
| 58 | MP0005464_abnormal_platelet_physiology | 1.23316008 |
| 59 | MP0003724_increased_susceptibility_to | 1.20945749 |
| 60 | MP0008872_abnormal_physiological_respon | 1.19162859 |
| 61 | MP0002132_abnormal_respiratory_system | 1.16307311 |
| 62 | MP0006054_spinal_hemorrhage | 1.15789523 |
| 63 | MP0002876_abnormal_thyroid_physiology | 1.12606419 |
| 64 | MP0005365_abnormal_bile_salt | 1.11777856 |
| 65 | MP0002118_abnormal_lipid_homeostasis | 1.11364242 |
| 66 | MP0000462_abnormal_digestive_system | 1.11227849 |
| 67 | MP0001485_abnormal_pinna_reflex | 1.09897683 |
| 68 | MP0005083_abnormal_biliary_tract | 1.08438627 |
| 69 | MP0005666_abnormal_adipose_tissue | 1.07802778 |
| 70 | MP0003075_altered_response_to | 1.04028293 |
| 71 | MP0004742_abnormal_vestibular_system | 1.02478148 |
| 72 | MP0005167_abnormal_blood-brain_barrier | 1.01285935 |
| 73 | MP0003283_abnormal_digestive_organ | 1.00996825 |
| 74 | MP0002822_catalepsy | 1.00350315 |
| 75 | MP0003634_abnormal_glial_cell | 1.00200175 |
| 76 | MP0000537_abnormal_urethra_morphology | 0.97081687 |
| 77 | MP0001663_abnormal_digestive_system | 0.96553714 |
| 78 | MP0005084_abnormal_gallbladder_morpholo | 0.94797669 |
| 79 | MP0000747_muscle_weakness | 0.94422471 |
| 80 | MP0004782_abnormal_surfactant_physiolog | 0.94410902 |
| 81 | MP0010329_abnormal_lipoprotein_level | 0.93501694 |
| 82 | MP0002098_abnormal_vibrissa_morphology | 0.91489557 |
| 83 | MP0002006_tumorigenesis | 0.91208974 |
| 84 | MP0003303_peritoneal_inflammation | 0.90255873 |
| 85 | MP0009642_abnormal_blood_homeostasis | 0.89780905 |
| 86 | MP0002229_neurodegeneration | 0.88193608 |
| 87 | MP0001905_abnormal_dopamine_level | 0.88036181 |
| 88 | MP0005448_abnormal_energy_balance | 0.87341169 |
| 89 | MP0004272_abnormal_basement_membrane | 0.86102841 |
| 90 | MP0005408_hypopigmentation | 0.85237445 |
| 91 | MP0000751_myopathy | 0.85119827 |
| 92 | MP0001666_abnormal_nutrient_absorption | 0.84133391 |
| 93 | MP0009115_abnormal_fat_cell | 0.82920549 |
| 94 | MP0005166_decreased_susceptibility_to | 0.82404305 |
| 95 | MP0002998_abnormal_bone_remodeling | 0.80256456 |
| 96 | MP0003633_abnormal_nervous_system | 0.78584761 |
| 97 | MP0000230_abnormal_systemic_arterial | 0.78455038 |
| 98 | MP0002089_abnormal_postnatal_growth/wei | 0.78442061 |
| 99 | MP0005319_abnormal_enzyme/_coenzyme | 0.78409888 |
| 100 | MP0003638_abnormal_response/metabolism_ | 0.77303440 |
| 101 | MP0002332_abnormal_exercise_endurance | 0.76841660 |
| 102 | MP0002295_abnormal_pulmonary_circulatio | 0.75653663 |
| 103 | MP0000858_altered_metastatic_potential | 0.75409636 |
| 104 | MP0008961_abnormal_basal_metabolism | 0.74378339 |
| 105 | MP0002971_abnormal_brown_adipose | 0.73638135 |
| 106 | MP0003315_abnormal_perineum_morphology | 0.73006201 |
| 107 | MP0002064_seizures | 0.72260063 |
| 108 | MP0004270_analgesia | 0.68967128 |
| 109 | MP0009764_decreased_sensitivity_to | 0.67050995 |
| 110 | MP0001849_ear_inflammation | 0.67040557 |
| 111 | MP0010771_integument_phenotype | 0.66554836 |
| 112 | MP0003172_abnormal_lysosome_physiology | 0.65790875 |
| 113 | MP0004510_myositis | 0.65695596 |
| 114 | MP0002249_abnormal_larynx_morphology | 0.65503186 |
| 115 | MP0000609_abnormal_liver_physiology | 0.63259749 |
| 116 | MP0003221_abnormal_cardiomyocyte_apopto | 0.62623302 |
| 117 | MP0004147_increased_porphyrin_level | 0.62184475 |
| 118 | MP0005310_abnormal_salivary_gland | 0.62095989 |
| 119 | MP0008260_abnormal_autophagy | 0.61364742 |
| 120 | MP0006036_abnormal_mitochondrial_physio | 0.61095044 |
| 121 | MP0001188_hyperpigmentation | 0.60989091 |
| 122 | MP0005535_abnormal_body_temperature | 0.60517667 |
| 123 | MP0002078_abnormal_glucose_homeostasis | 0.59818513 |
| 124 | MP0008469_abnormal_protein_level | 0.59792755 |
| 125 | MP0003631_nervous_system_phenotype | 0.59427998 |
| 126 | MP0002272_abnormal_nervous_system | 0.59137892 |
| 127 | MP0000598_abnormal_liver_morphology | 0.59100762 |
| 128 | MP0003705_abnormal_hypodermis_morpholog | 0.58938417 |
| 129 | MP0005381_digestive/alimentary_phenotyp | 0.58763655 |
| 130 | MP0003953_abnormal_hormone_level | 0.58520797 |
| 131 | MP0005266_abnormal_metabolism | 0.57981461 |
| 132 | MP0009765_abnormal_xenobiotic_induced | 0.57293834 |
| 133 | MP0005409_darkened_coat_color | 0.56835326 |
| 134 | MP0008874_decreased_physiological_sensi | 0.56757074 |
| 135 | MP0003828_pulmonary_edema | 0.56200132 |
| 136 | MP0009780_abnormal_chondrocyte_physiolo | 0.55570241 |
| 137 | MP0005165_increased_susceptibility_to | 0.55284827 |
| 138 | MP0004947_skin_inflammation | 0.55024787 |
| 139 | MP0005376_homeostasis/metabolism_phenot | 0.54058358 |
| 140 | MP0005375_adipose_tissue_phenotype | 0.53998313 |
| 141 | MP0003300_gastrointestinal_ulcer | 0.53571760 |
| 142 | MP0001664_abnormal_digestion | 0.53133614 |
| 143 | MP0001851_eye_inflammation | 0.53068574 |
| 144 | MP0001963_abnormal_hearing_physiology | 0.51218192 |
| 145 | MP0008789_abnormal_olfactory_epithelium | 0.51180433 |
| 146 | MP0001845_abnormal_inflammatory_respons | 0.51053884 |
| 147 | MP0005257_abnormal_intraocular_pressure | 0.49283648 |
| 148 | MP0006138_congestive_heart_failure | 0.47989537 |
| 149 | MP0009333_abnormal_splenocyte_physiolog | 0.47135007 |
| 150 | MP0000534_abnormal_ureter_morphology | 0.45936897 |
| 151 | MP0000249_abnormal_blood_vessel | 0.45732617 |
| 152 | MP0003693_abnormal_embryo_hatching | 0.45505377 |
| 153 | MP0005334_abnormal_fat_pad | 0.44016565 |
| 154 | MP0000681_abnormal_thyroid_gland | 0.41700687 |
| 155 | MP0000516_abnormal_urinary_system | 0.40959717 |
| 156 | MP0005367_renal/urinary_system_phenotyp | 0.40959717 |
| 157 | MP0009931_abnormal_skin_appearance | 0.40196989 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypobetalipoproteinemia (HP:0003563) | 5.58909270 |
| 2 | Malnutrition (HP:0004395) | 5.02381216 |
| 3 | Acanthocytosis (HP:0001927) | 4.90485885 |
| 4 | Gout (HP:0001997) | 4.57248863 |
| 5 | Proximal tubulopathy (HP:0000114) | 4.53901027 |
| 6 | Delayed epiphyseal ossification (HP:0002663) | 4.42082333 |
| 7 | Metabolic alkalosis (HP:0200114) | 4.21474927 |
| 8 | Diaphragmatic weakness (HP:0009113) | 4.10140003 |
| 9 | Hypophosphatemic rickets (HP:0004912) | 4.07928603 |
| 10 | Thin bony cortex (HP:0002753) | 3.97419134 |
| 11 | Hypokalemic alkalosis (HP:0001949) | 3.96590263 |
| 12 | Fat malabsorption (HP:0002630) | 3.93637593 |
| 13 | Rickets (HP:0002748) | 3.88517437 |
| 14 | Neurofibrillary tangles (HP:0002185) | 3.88514909 |
| 15 | Hemorrhage of the eye (HP:0011885) | 3.88276725 |
| 16 | Hypomagnesemia (HP:0002917) | 3.87975142 |
| 17 | Deep venous thrombosis (HP:0002625) | 3.87841277 |
| 18 | Increased circulating renin level (HP:0000848) | 3.79925179 |
| 19 | Systemic lupus erythematosus (HP:0002725) | 3.79223565 |
| 20 | Abnormal urine phosphate concentration (HP:0012599) | 3.76943222 |
| 21 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.67534187 |
| 22 | Generalized aminoaciduria (HP:0002909) | 3.60585378 |
| 23 | Widely patent fontanelles and sutures (HP:0004492) | 3.56950525 |
| 24 | Polyuria (HP:0000103) | 3.55903194 |
| 25 | Flat occiput (HP:0005469) | 3.42495440 |
| 26 | Abnormal urine output (HP:0012590) | 3.41931293 |
| 27 | Abnormality of renal excretion (HP:0011036) | 3.40844342 |
| 28 | Chronic diarrhea (HP:0002028) | 3.39606895 |
| 29 | Nausea (HP:0002018) | 3.39570435 |
| 30 | Glycosuria (HP:0003076) | 3.36069671 |
| 31 | Abnormality of urine glucose concentration (HP:0011016) | 3.36069671 |
| 32 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.30992629 |
| 33 | Abnormality of the costochondral junction (HP:0000919) | 3.28915225 |
| 34 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.26186265 |
| 35 | Enlarged epiphyses (HP:0010580) | 3.22628907 |
| 36 | Hypolipoproteinemia (HP:0010981) | 3.19287174 |
| 37 | Abnormality of vitamin B metabolism (HP:0004340) | 3.16551592 |
| 38 | Abnormality of magnesium homeostasis (HP:0004921) | 3.14247638 |
| 39 | Hyperphosphaturia (HP:0003109) | 3.12707927 |
| 40 | Abnormal drinking behavior (HP:0030082) | 3.11448817 |
| 41 | Polydipsia (HP:0001959) | 3.11448817 |
| 42 | Cerebral inclusion bodies (HP:0100314) | 3.11122443 |
| 43 | Increased purine levels (HP:0004368) | 3.09854336 |
| 44 | Hyperuricemia (HP:0002149) | 3.09854336 |
| 45 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.08256152 |
| 46 | Abnormality of chloride homeostasis (HP:0011422) | 3.07095071 |
| 47 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.06074275 |
| 48 | Flat acetabular roof (HP:0003180) | 3.04242467 |
| 49 | Intrahepatic cholestasis (HP:0001406) | 3.03548453 |
| 50 | Menorrhagia (HP:0000132) | 3.03245314 |
| 51 | Hypercalciuria (HP:0002150) | 3.02938990 |
| 52 | Hyperactive renin-angiotensin system (HP:0000841) | 2.99234014 |
| 53 | Hyperlipoproteinemia (HP:0010980) | 2.99057641 |
| 54 | Abnormality of purine metabolism (HP:0004352) | 2.97814749 |
| 55 | Pigmentary retinal degeneration (HP:0001146) | 2.97213902 |
| 56 | Facial shape deformation (HP:0011334) | 2.95308118 |
| 57 | Potter facies (HP:0002009) | 2.95308118 |
| 58 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.95000931 |
| 59 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.93913487 |
| 60 | Petechiae (HP:0000967) | 2.92370735 |
| 61 | Hypophosphatemia (HP:0002148) | 2.89843128 |
| 62 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.88749380 |
| 63 | Axonal loss (HP:0003447) | 2.85948599 |
| 64 | Abnormal tarsal ossification (HP:0008369) | 2.85053669 |
| 65 | Hyperglycinuria (HP:0003108) | 2.84581103 |
| 66 | Decreased circulating renin level (HP:0003351) | 2.84451504 |
| 67 | Glomerulonephritis (HP:0000099) | 2.74053914 |
| 68 | Elevated alkaline phosphatase (HP:0003155) | 2.72771836 |
| 69 | Confusion (HP:0001289) | 2.69497933 |
| 70 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.69162522 |
| 71 | Abdominal distention (HP:0003270) | 2.68546221 |
| 72 | Abnormality of glycine metabolism (HP:0010895) | 2.64989479 |
| 73 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.64989479 |
| 74 | Alkalosis (HP:0001948) | 2.61937417 |
| 75 | Vacuolated lymphocytes (HP:0001922) | 2.61880376 |
| 76 | Distal lower limb muscle weakness (HP:0009053) | 2.60916972 |
| 77 | Xanthomatosis (HP:0000991) | 2.60302249 |
| 78 | Poikilocytosis (HP:0004447) | 2.59319502 |
| 79 | Prolonged neonatal jaundice (HP:0006579) | 2.54982531 |
| 80 | Ketosis (HP:0001946) | 2.53663511 |
| 81 | Epidermoid cyst (HP:0200040) | 2.53211887 |
| 82 | Megaloblastic anemia (HP:0001889) | 2.49218123 |
| 83 | Purpura (HP:0000979) | 2.47527034 |
| 84 | Complement deficiency (HP:0004431) | 2.38713366 |
| 85 | Nephrolithiasis (HP:0000787) | 2.38222793 |
| 86 | Right ventricular cardiomyopathy (HP:0011663) | 2.37176267 |
| 87 | Renal tubular dysfunction (HP:0000124) | 2.35909288 |
| 88 | Hypotension (HP:0002615) | 2.32518291 |
| 89 | Renal salt wasting (HP:0000127) | 2.31083853 |
| 90 | Ketoacidosis (HP:0001993) | 2.30531272 |
| 91 | Muscle fiber splitting (HP:0003555) | 2.29927682 |
| 92 | Hyperammonemia (HP:0001987) | 2.29785066 |
| 93 | Abnormality of renal resorption (HP:0011038) | 2.29531345 |
| 94 | Vascular calcification (HP:0004934) | 2.29257244 |
| 95 | Hyperaldosteronism (HP:0000859) | 2.26181043 |
| 96 | Renal tubular acidosis (HP:0001947) | 2.24541589 |
| 97 | Abnormality of methionine metabolism (HP:0010901) | 2.22895412 |
| 98 | Abnormality of complement system (HP:0005339) | 2.22411057 |
| 99 | Steatorrhea (HP:0002570) | 2.20030591 |
| 100 | Hyperparathyroidism (HP:0000843) | 2.19914721 |
| 101 | Loss of speech (HP:0002371) | 2.19826603 |
| 102 | Skin nodule (HP:0200036) | 2.18582662 |
| 103 | Abnormality of renin-angiotensin system (HP:0000847) | 2.16844221 |
| 104 | Cholecystitis (HP:0001082) | 2.16779348 |
| 105 | Abnormal gallbladder physiology (HP:0012438) | 2.16779348 |
| 106 | Abnormality of macrophages (HP:0004311) | 2.16285442 |
| 107 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.15663284 |
| 108 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.15663284 |
| 109 | Dicarboxylic aciduria (HP:0003215) | 2.15178069 |
| 110 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.15178069 |
| 111 | High anterior hairline (HP:0009890) | 2.14566221 |
| 112 | Prolonged bleeding time (HP:0003010) | 2.14496035 |
| 113 | Wide cranial sutures (HP:0010537) | 2.14167755 |
| 114 | Prolonged partial thromboplastin time (HP:0003645) | 2.13859812 |
| 115 | Focal segmental glomerulosclerosis (HP:0000097) | 2.13599201 |
| 116 | Joint hemorrhage (HP:0005261) | 2.12440447 |
| 117 | Abnormality of carpal bone ossification (HP:0006257) | 2.11094234 |
| 118 | Gastrointestinal dysmotility (HP:0002579) | 2.10433308 |
| 119 | Metaphyseal irregularity (HP:0003025) | 2.08779994 |
| 120 | Hypercholesterolemia (HP:0003124) | 2.08170141 |
| 121 | Methylmalonic aciduria (HP:0012120) | 2.06346496 |
| 122 | Cardiovascular calcification (HP:0011915) | 2.03855014 |
| 123 | Delayed CNS myelination (HP:0002188) | 2.03548677 |
| 124 | Abnormality of nucleobase metabolism (HP:0010932) | 2.02506067 |
| 125 | Tetany (HP:0001281) | 2.00884765 |
| 126 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.00274826 |
| 127 | Progressive external ophthalmoplegia (HP:0000590) | 1.98337629 |
| 128 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.97821974 |
| 129 | Ileus (HP:0002595) | 1.97483797 |
| 130 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.97076679 |
| 131 | Seborrheic dermatitis (HP:0001051) | 1.95962760 |
| 132 | Glomerulosclerosis (HP:0000096) | 1.95670798 |
| 133 | Abnormal auditory evoked potentials (HP:0006958) | 1.94292616 |
| 134 | Nephritis (HP:0000123) | 1.94245485 |
| 135 | Hypoglycemic coma (HP:0001325) | 1.94228587 |
| 136 | Hyporeflexia of lower limbs (HP:0002600) | 1.94127005 |
| 137 | Abnormality of vitamin metabolism (HP:0100508) | 1.93392121 |
| 138 | Abnormality of the common coagulation pathway (HP:0010990) | 1.92364514 |
| 139 | Spastic tetraparesis (HP:0001285) | 1.90284337 |
| 140 | Onion bulb formation (HP:0003383) | 1.89522174 |
| 141 | Abnormal hair laboratory examination (HP:0003328) | 1.89485173 |
| 142 | Dry hair (HP:0011359) | 1.88974366 |
| 143 | Hypokalemia (HP:0002900) | 1.88247598 |
| 144 | Termporal pattern (HP:0011008) | 1.86160606 |
| 145 | Insidious onset (HP:0003587) | 1.86160606 |
| 146 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.85959701 |
| 147 | Villous atrophy (HP:0011473) | 1.85959701 |
| 148 | Sensory axonal neuropathy (HP:0003390) | 1.84795717 |
| 149 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.84577586 |
| 150 | Hydroxyprolinuria (HP:0003080) | 1.83360312 |
| 151 | Abnormality of proline metabolism (HP:0010907) | 1.83360312 |
| 152 | Protuberant abdomen (HP:0001538) | 1.80097120 |
| 153 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.78844925 |
| 154 | Abnormal platelet function (HP:0011869) | 1.77213298 |
| 155 | Impaired platelet aggregation (HP:0003540) | 1.77213298 |
| 156 | Increased mean platelet volume (HP:0011877) | 1.74871611 |
| 157 | Vaginal fistula (HP:0004320) | 1.74178889 |
| 158 | Abnormal foot bone ossification (HP:0010675) | 1.73843017 |
| 159 | Ankle clonus (HP:0011448) | 1.72617031 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OXSR1 | 5.19836134 |
| 2 | WNK4 | 5.12723770 |
| 3 | STK39 | 4.68111743 |
| 4 | ACVR1B | 4.65076456 |
| 5 | EPHA2 | 3.64595876 |
| 6 | RIPK1 | 2.89282877 |
| 7 | GRK7 | 2.76143964 |
| 8 | PKN2 | 2.73965510 |
| 9 | STK10 | 2.66284592 |
| 10 | MST4 | 2.65468350 |
| 11 | PRKG2 | 2.64324217 |
| 12 | TRIB3 | 2.61911250 |
| 13 | TGFBR2 | 2.59056873 |
| 14 | BCKDK | 2.58822121 |
| 15 | SIK1 | 2.52555886 |
| 16 | EPHB1 | 2.51100467 |
| 17 | WNK3 | 2.29056620 |
| 18 | CLK1 | 2.19687035 |
| 19 | MAP3K10 | 2.11744345 |
| 20 | LMTK2 | 2.05725891 |
| 21 | ICK | 2.03391109 |
| 22 | CDK19 | 2.00613524 |
| 23 | MOS | 1.83546983 |
| 24 | CDK12 | 1.82602480 |
| 25 | FGFR3 | 1.80665887 |
| 26 | PBK | 1.73356962 |
| 27 | MAP3K11 | 1.67079015 |
| 28 | MAPKAPK5 | 1.64584335 |
| 29 | MAPK15 | 1.60998975 |
| 30 | NME2 | 1.55944519 |
| 31 | PIK3CA | 1.48572231 |
| 32 | WNK1 | 1.47614849 |
| 33 | ABL2 | 1.42315892 |
| 34 | PRKCI | 1.40084265 |
| 35 | PKN1 | 1.39539315 |
| 36 | DAPK2 | 1.37353059 |
| 37 | MARK1 | 1.37121045 |
| 38 | PTK2 | 1.34839979 |
| 39 | BCR | 1.34313834 |
| 40 | LRRK2 | 1.33765433 |
| 41 | MAP3K2 | 1.28608979 |
| 42 | MET | 1.17530941 |
| 43 | TESK2 | 1.15753878 |
| 44 | EEF2K | 1.15748972 |
| 45 | AKT3 | 1.10051601 |
| 46 | MAP3K9 | 1.07929327 |
| 47 | GRK5 | 1.06639678 |
| 48 | MST1R | 1.06165504 |
| 49 | PDGFRA | 1.04930756 |
| 50 | MATK | 1.03357962 |
| 51 | TESK1 | 1.03039890 |
| 52 | NTRK1 | 1.02829041 |
| 53 | NME1 | 1.02256582 |
| 54 | KSR2 | 1.01755600 |
| 55 | RET | 1.01047643 |
| 56 | MAP3K8 | 1.00615505 |
| 57 | BRSK2 | 0.99173192 |
| 58 | SMG1 | 0.92168531 |
| 59 | PTK6 | 0.90717254 |
| 60 | MAP3K1 | 0.88889819 |
| 61 | STK11 | 0.88503964 |
| 62 | ERN1 | 0.85206483 |
| 63 | MAPK11 | 0.84381182 |
| 64 | CAMK2B | 0.84336906 |
| 65 | TAOK1 | 0.84303694 |
| 66 | EPHA3 | 0.83611753 |
| 67 | ERBB2 | 0.82715601 |
| 68 | CDC42BPA | 0.81468716 |
| 69 | CSNK1G1 | 0.79830450 |
| 70 | JAK2 | 0.79302802 |
| 71 | TYRO3 | 0.79160615 |
| 72 | ADRBK1 | 0.79090543 |
| 73 | GSK3A | 0.77970725 |
| 74 | MAP2K6 | 0.75422372 |
| 75 | GRK6 | 0.75328670 |
| 76 | PDK3 | 0.74214201 |
| 77 | PDK4 | 0.74214201 |
| 78 | TYK2 | 0.73379313 |
| 79 | ROCK2 | 0.69071136 |
| 80 | PAK2 | 0.68924608 |
| 81 | TLK1 | 0.68374872 |
| 82 | MAP2K2 | 0.65467514 |
| 83 | CSNK1G3 | 0.64787437 |
| 84 | KDR | 0.64421255 |
| 85 | PRKCQ | 0.63720356 |
| 86 | PTK2B | 0.63559250 |
| 87 | EPHB2 | 0.63073712 |
| 88 | PRKCH | 0.61659054 |
| 89 | UHMK1 | 0.61500269 |
| 90 | PRKACG | 0.60795223 |
| 91 | PRKAA2 | 0.60464302 |
| 92 | RIPK4 | 0.60091795 |
| 93 | FER | 0.59894512 |
| 94 | CDK7 | 0.59730000 |
| 95 | MYLK | 0.59330661 |
| 96 | STK24 | 0.58566672 |
| 97 | ADRBK2 | 0.58070693 |
| 98 | PAK4 | 0.57468334 |
| 99 | CDK14 | 0.57324732 |
| 100 | PRKACB | 0.55863748 |
| 101 | IRAK3 | 0.54574709 |
| 102 | SGK494 | 0.53780055 |
| 103 | SGK223 | 0.53780055 |
| 104 | CDK15 | 0.53312364 |
| 105 | EIF2AK1 | 0.52505996 |
| 106 | PDPK1 | 0.52261101 |
| 107 | PDK2 | 0.51806081 |
| 108 | LIMK1 | 0.51740463 |
| 109 | BMX | 0.51012814 |
| 110 | FGFR4 | 0.49669356 |
| 111 | INSR | 0.48969166 |
| 112 | ALK | 0.46771217 |
| 113 | CSNK1A1L | 0.46173044 |
| 114 | CDK18 | 0.45931738 |
| 115 | BTK | 0.45485571 |
| 116 | ARAF | 0.45133143 |
| 117 | PRKCE | 0.44708523 |
| 118 | CSNK1D | 0.43851234 |
| 119 | CAMK2D | 0.43716238 |
| 120 | PRKD1 | 0.43487645 |
| 121 | CDK5 | 0.43262508 |
| 122 | EIF2AK2 | 0.43125911 |
| 123 | IKBKB | 0.42861347 |
| 124 | DYRK1B | 0.42700240 |
| 125 | CDK11A | 0.42546326 |
| 126 | CAMK2G | 0.40698910 |
| 127 | PRKCZ | 0.40027078 |
| 128 | ILK | 0.39795523 |
| 129 | FGFR2 | 0.39674256 |
| 130 | TNIK | 0.38761091 |
| 131 | ITK | 0.38525321 |
| 132 | PRKCD | 0.38082519 |
| 133 | CAMKK2 | 0.38004400 |
| 134 | FGFR1 | 0.37511364 |
| 135 | HCK | 0.36866959 |
| 136 | TEC | 0.36816268 |
| 137 | CSNK1G2 | 0.36799433 |
| 138 | FYN | 0.36328592 |
| 139 | PDK1 | 0.36207154 |
| 140 | MAP4K1 | 0.36027614 |
| 141 | FGR | 0.34759609 |
| 142 | DDR2 | 0.34546533 |
| 143 | MAP3K13 | 0.33824251 |
| 144 | CSF1R | 0.33407123 |
| 145 | MAPKAPK3 | 0.33070244 |
| 146 | SRC | 0.31941436 |
| 147 | PRKCA | 0.30661795 |
| 148 | MTOR | 0.29556878 |
| 149 | SGK1 | 0.27925682 |
| 150 | PRKAA1 | 0.26160309 |
| 151 | MAPKAPK2 | 0.26051038 |
| 152 | CSNK1E | 0.25136107 |
| 153 | CSNK1A1 | 0.24844189 |
| 154 | TAOK3 | 0.20675530 |
| 155 | MAP3K3 | 0.18082441 |
| 156 | DMPK | 0.16071023 |
| 157 | BRSK1 | 0.16067567 |
| 158 | RPS6KA2 | 0.15333028 |
| 159 | MAPK3 | 0.14146989 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.59040392 |
| 2 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.54074983 |
| 3 | Renin-angiotensin system_Homo sapiens_hsa04614 | 3.49564906 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.30815097 |
| 5 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.97697196 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.64017350 |
| 7 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.47580769 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.42532818 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.40823741 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.39931014 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.36157585 |
| 12 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.32773488 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.29840385 |
| 14 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.28999927 |
| 15 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.03573725 |
| 16 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.96186199 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.90075480 |
| 18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.89641391 |
| 19 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.87961213 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 1.86720586 |
| 21 | Galactose metabolism_Homo sapiens_hsa00052 | 1.83583022 |
| 22 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.76749482 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.75758265 |
| 24 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.74176639 |
| 25 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.72881575 |
| 26 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.72584699 |
| 27 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.69796242 |
| 28 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.65240259 |
| 29 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.62881857 |
| 30 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.51172896 |
| 31 | Bile secretion_Homo sapiens_hsa04976 | 1.50817370 |
| 32 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.48478066 |
| 33 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.45626672 |
| 34 | Parkinsons disease_Homo sapiens_hsa05012 | 1.44729669 |
| 35 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.36884549 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.34238616 |
| 37 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.25021589 |
| 38 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.21443600 |
| 39 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.21138742 |
| 40 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.19774346 |
| 41 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.18919465 |
| 42 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.17559849 |
| 43 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.15643175 |
| 44 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.15383264 |
| 45 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.15382302 |
| 46 | Alzheimers disease_Homo sapiens_hsa05010 | 1.14317347 |
| 47 | Mineral absorption_Homo sapiens_hsa04978 | 1.09546829 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.08489093 |
| 49 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.06796853 |
| 50 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.06321866 |
| 51 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.05148807 |
| 52 | Other glycan degradation_Homo sapiens_hsa00511 | 0.99416222 |
| 53 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.98382913 |
| 54 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.93074637 |
| 55 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.92758911 |
| 56 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.91415801 |
| 57 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.86944870 |
| 58 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.85744341 |
| 59 | Lysosome_Homo sapiens_hsa04142 | 0.85298418 |
| 60 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.83816376 |
| 61 | Sulfur relay system_Homo sapiens_hsa04122 | 0.83388814 |
| 62 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.80953465 |
| 63 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.80300716 |
| 64 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.79586378 |
| 65 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.79121681 |
| 66 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.78988234 |
| 67 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.78527519 |
| 68 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.72620028 |
| 69 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.72411109 |
| 70 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.71831873 |
| 71 | Lysine degradation_Homo sapiens_hsa00310 | 0.71033722 |
| 72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.70247546 |
| 73 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.70187808 |
| 74 | ABC transporters_Homo sapiens_hsa02010 | 0.69898978 |
| 75 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.67191994 |
| 76 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.65348932 |
| 77 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.62026038 |
| 78 | Huntingtons disease_Homo sapiens_hsa05016 | 0.59336286 |
| 79 | Metabolic pathways_Homo sapiens_hsa01100 | 0.59302719 |
| 80 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.58829460 |
| 81 | Insulin resistance_Homo sapiens_hsa04931 | 0.57640019 |
| 82 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.57275450 |
| 83 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.53394912 |
| 84 | Retinol metabolism_Homo sapiens_hsa00830 | 0.49062967 |
| 85 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.48536589 |
| 86 | Cocaine addiction_Homo sapiens_hsa05030 | 0.45636208 |
| 87 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.44441852 |
| 88 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.42037627 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.39809601 |
| 90 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.39759818 |
| 91 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.36757513 |
| 92 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.36560389 |
| 93 | Phagosome_Homo sapiens_hsa04145 | 0.35269812 |
| 94 | Tight junction_Homo sapiens_hsa04530 | 0.34133569 |
| 95 | Asthma_Homo sapiens_hsa05310 | 0.32751928 |
| 96 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.31289435 |
| 97 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.30105070 |
| 98 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.29835399 |
| 99 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.29698978 |
| 100 | Protein export_Homo sapiens_hsa03060 | 0.29320312 |
| 101 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.29248041 |
| 102 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.29094014 |
| 103 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.26443675 |
| 104 | Axon guidance_Homo sapiens_hsa04360 | 0.25248136 |
| 105 | Bladder cancer_Homo sapiens_hsa05219 | 0.24788431 |
| 106 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.24728017 |
| 107 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.24229520 |
| 108 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.23636766 |
| 109 | Salivary secretion_Homo sapiens_hsa04970 | 0.22573449 |
| 110 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.21146560 |
| 111 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.21046347 |
| 112 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.19623196 |
| 113 | Renin secretion_Homo sapiens_hsa04924 | 0.19194614 |
| 114 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.18946829 |
| 115 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.17687916 |
| 116 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.16304702 |
| 117 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.14942581 |
| 118 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.12855033 |
| 119 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.12059494 |
| 120 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.09628121 |
| 121 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.09248107 |
| 122 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.07596583 |
| 123 | Hepatitis C_Homo sapiens_hsa05160 | 0.05243037 |
| 124 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.04474213 |
| 125 | Platelet activation_Homo sapiens_hsa04611 | 0.02716222 |
| 126 | Thyroid cancer_Homo sapiens_hsa05216 | 0.01824000 |
| 127 | Prostate cancer_Homo sapiens_hsa05215 | -0.0304879 |
| 128 | Endometrial cancer_Homo sapiens_hsa05213 | -0.0101320 |

